Is there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Mullerian tumor) of the uterus?
- 1 June 1995
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 5 (4) , 310-313
- https://doi.org/10.1046/j.1525-1438.1995.05040310.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapyGynecologic Oncology, 1992
- Retrospective analysis of 318 cases of uterine sarcomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Breast cancer prevention with tamoxifen: The role of tamoxifen in the prevention of breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Estrogen and progesterone receptors in endometrial cancer and their prognostic relevanceGynecologic Oncology, 1990
- Tamoxifen for breast cancer: Associated endometrial cancerCancer, 1990
- Autoradiographic localization of [3H]hydroxytamoxifen to uterine oestrogen- and antioestrogen-binding sitesJournal of Molecular Histology, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- TAMOXIFEN AS RISK FACTOR FOR CARCINOMA OF CORPUS UTERIThe Lancet, 1988
- Endometrial “sarcomas” complicating ovarian thecoma, polycystic ovarian disease and estrogen therapyGynecologic Oncology, 1985
- Malignant mixed Müllerian tumor of the endometrium in a young woman with polycystic ovariesCancer, 1983